世界の大人・小児用ワクチン市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Adult and Pediatric Vaccines Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A14907 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、大人・小児用ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。大人・小児用ワクチンの種類別市場規模（大人用ワクチン、小児用ワクチン）、用途別市場規模（病院、医療センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・大人・小児用ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline、Sanofi、Merck、Novartis、Pfizer、AstraZeneca、Johnson and Johnson、Takeda Pharmaceutical、Bavarian Nordic、LG Life Sciences、Sinovac Biotech ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：大人用ワクチン、小児用ワクチン ・用途別分析2016年-2026年：病院、医療センター、その他 ・大人・小児用ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・大人・小児用ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・大人・小児用ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・大人・小児用ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・大人・小児用ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Adult and Pediatric Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Adult and Pediatric Vaccines size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Adult and Pediatric Vaccines market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Adult and Pediatric Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Adult Vaccines
Pediatric Vaccines

Market segment by Application, can be divided into
Hospitals
Medical Care Centers
Others

Market segment by players, this report covers
GlaxoSmithKline
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Johnson and Johnson
Takeda Pharmaceutical
Bavarian Nordic
LG Life Sciences
Sinovac Biotech

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Adult and Pediatric Vaccines
1.2 Classification of Adult and Pediatric Vaccines by Type
1.2.1 Overview: Global Adult and Pediatric Vaccines Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Adult and Pediatric Vaccines Revenue Market Share by Type in 2020
1.2.3 Adult Vaccines
1.2.4 Pediatric Vaccines
1.3 Global Adult and Pediatric Vaccines Market by Application
1.3.1 Overview: Global Adult and Pediatric Vaccines Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Medical Care Centers
1.3.4 Others
1.4 Global Adult and Pediatric Vaccines Market Size & Forecast
1.5 Global Adult and Pediatric Vaccines Market Size and Forecast by Region
1.5.1 Global Adult and Pediatric Vaccines Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Adult and Pediatric Vaccines Market Size by Region, (2016-2021)
1.5.3 North America Adult and Pediatric Vaccines Market Size and Prospect (2016-2026)
1.5.4 Europe Adult and Pediatric Vaccines Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Adult and Pediatric Vaccines Market Size and Prospect (2016-2026)
1.5.6 South America Adult and Pediatric Vaccines Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Adult and Pediatric Vaccines Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Adult and Pediatric Vaccines Market Drivers
1.6.2 Adult and Pediatric Vaccines Market Restraints
1.6.3 Adult and Pediatric Vaccines Trends Analysis
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Adult and Pediatric Vaccines Product and Solutions
2.1.4 GlaxoSmithKline Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GlaxoSmithKline Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Adult and Pediatric Vaccines Product and Solutions
2.2.4 Sanofi Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Adult and Pediatric Vaccines Product and Solutions
2.3.4 Merck Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Adult and Pediatric Vaccines Product and Solutions
2.4.4 Novartis Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Adult and Pediatric Vaccines Product and Solutions
2.5.4 Pfizer Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Adult and Pediatric Vaccines Product and Solutions
2.6.4 AstraZeneca Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 Johnson and Johnson
2.7.1 Johnson and Johnson Details
2.7.2 Johnson and Johnson Major Business
2.7.3 Johnson and Johnson Adult and Pediatric Vaccines Product and Solutions
2.7.4 Johnson and Johnson Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Johnson and Johnson Recent Developments and Future Plans
2.8 Takeda Pharmaceutical
2.8.1 Takeda Pharmaceutical Details
2.8.2 Takeda Pharmaceutical Major Business
2.8.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Product and Solutions
2.8.4 Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Takeda Pharmaceutical Recent Developments and Future Plans
2.9 Bavarian Nordic
2.9.1 Bavarian Nordic Details
2.9.2 Bavarian Nordic Major Business
2.9.3 Bavarian Nordic Adult and Pediatric Vaccines Product and Solutions
2.9.4 Bavarian Nordic Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Bavarian Nordic Recent Developments and Future Plans
2.10 LG Life Sciences
2.10.1 LG Life Sciences Details
2.10.2 LG Life Sciences Major Business
2.10.3 LG Life Sciences Adult and Pediatric Vaccines Product and Solutions
2.10.4 LG Life Sciences Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 LG Life Sciences Recent Developments and Future Plans
2.11 Sinovac Biotech
2.11.1 Sinovac Biotech Details
2.11.2 Sinovac Biotech Major Business
2.11.3 Sinovac Biotech Adult and Pediatric Vaccines Product and Solutions
2.11.4 Sinovac Biotech Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Sinovac Biotech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Adult and Pediatric Vaccines Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Adult and Pediatric Vaccines Players Market Share
3.2.2 Top 10 Adult and Pediatric Vaccines Players Market Share
3.2.3 Market Competition Trend
3.3 Adult and Pediatric Vaccines Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Adult and Pediatric Vaccines Revenue and Market Share by Type (2016-2021)
4.2 Global Adult and Pediatric Vaccines Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Adult and Pediatric Vaccines Revenue Market Share by Application (2016-2021)
5.2 Adult and Pediatric Vaccines Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Adult and Pediatric Vaccines Revenue by Type (2016-2026)
6.2 North America Adult and Pediatric Vaccines Revenue by Application (2016-2026)
6.3 North America Adult and Pediatric Vaccines Market Size by Country
6.3.1 North America Adult and Pediatric Vaccines Revenue by Country (2016-2026)
6.3.2 United States Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
6.3.3 Canada Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
6.3.4 Mexico Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Adult and Pediatric Vaccines Revenue by Type (2016-2026)
7.2 Europe Adult and Pediatric Vaccines Revenue by Application (2016-2026)
7.3 Europe Adult and Pediatric Vaccines Market Size by Country
7.3.1 Europe Adult and Pediatric Vaccines Revenue by Country (2016-2026)
7.3.2 Germany Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
7.3.3 France Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
7.3.5 Russia Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
7.3.6 Italy Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Adult and Pediatric Vaccines Revenue by Type (2016-2026)
8.2 Asia-Pacific Adult and Pediatric Vaccines Revenue by Application (2016-2026)
8.3 Asia-Pacific Adult and Pediatric Vaccines Market Size by Region
8.3.1 Asia-Pacific Adult and Pediatric Vaccines Revenue by Region (2016-2026)
8.3.2 China Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
8.3.3 Japan Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
8.3.4 South Korea Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
8.3.5 India Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
8.3.7 Australia Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Adult and Pediatric Vaccines Revenue by Type (2016-2026)
9.2 South America Adult and Pediatric Vaccines Revenue by Application (2016-2026)
9.3 South America Adult and Pediatric Vaccines Market Size by Country
9.3.1 South America Adult and Pediatric Vaccines Revenue by Country (2016-2026)
9.3.2 Brazil Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
9.3.3 Argentina Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Adult and Pediatric Vaccines Revenue by Type (2016-2026)
10.2 Middle East & Africa Adult and Pediatric Vaccines Revenue by Application (2016-2026)
10.3 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country
10.3.1 Middle East & Africa Adult and Pediatric Vaccines Revenue by Country (2016-2026)
10.3.2 Turkey Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
10.3.4 UAE Adult and Pediatric Vaccines Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Adult and Pediatric Vaccines Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Adult and Pediatric Vaccines Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Adult and Pediatric Vaccines Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Adult and Pediatric Vaccines Revenue (USD Million) by Region (2016-2021)
Table 5. Global Adult and Pediatric Vaccines Revenue Market Share by Region (2021-2026)
Table 6. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 7. GlaxoSmithKline Major Business
Table 8. GlaxoSmithKline Adult and Pediatric Vaccines Product and Solutions
Table 9. GlaxoSmithKline Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Sanofi Corporate Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Adult and Pediatric Vaccines Product and Solutions
Table 13. Sanofi Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Merck Corporate Information, Head Office, and Major Competitors
Table 15. Merck Major Business
Table 16. Merck Adult and Pediatric Vaccines Product and Solutions
Table 17. Merck Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Novartis Corporate Information, Head Office, and Major Competitors
Table 19. Novartis Major Business
Table 20. Novartis Adult and Pediatric Vaccines Product and Solutions
Table 21. Novartis Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Major Business
Table 24. Pfizer Adult and Pediatric Vaccines Product and Solutions
Table 25. Pfizer Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 27. AstraZeneca Major Business
Table 28. AstraZeneca Adult and Pediatric Vaccines Product and Solutions
Table 29. AstraZeneca Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Johnson and Johnson Corporate Information, Head Office, and Major Competitors
Table 31. Johnson and Johnson Major Business
Table 32. Johnson and Johnson Adult and Pediatric Vaccines Product and Solutions
Table 33. Johnson and Johnson Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Takeda Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 35. Takeda Pharmaceutical Major Business
Table 36. Takeda Pharmaceutical Adult and Pediatric Vaccines Product and Solutions
Table 37. Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Bavarian Nordic Corporate Information, Head Office, and Major Competitors
Table 39. Bavarian Nordic Major Business
Table 40. Bavarian Nordic Adult and Pediatric Vaccines Product and Solutions
Table 41. Bavarian Nordic Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. LG Life Sciences Corporate Information, Head Office, and Major Competitors
Table 43. LG Life Sciences Major Business
Table 44. LG Life Sciences Adult and Pediatric Vaccines Product and Solutions
Table 45. LG Life Sciences Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Sinovac Biotech Corporate Information, Head Office, and Major Competitors
Table 47. Sinovac Biotech Major Business
Table 48. Sinovac Biotech Adult and Pediatric Vaccines Product and Solutions
Table 49. Sinovac Biotech Adult and Pediatric Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Adult and Pediatric Vaccines Revenue (USD Million) by Players (2019-2021)
Table 51. Global Adult and Pediatric Vaccines Revenue Share by Players (2019-2021)
Table 52. Breakdown of Adult and Pediatric Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Adult and Pediatric Vaccines Players Head Office, Products and Services Provided
Table 54. Adult and Pediatric Vaccines Mergers & Acquisitions in the Past Five Years
Table 55. Adult and Pediatric Vaccines New Entrants and Expansion Plans
Table 56. Global Adult and Pediatric Vaccines Revenue (USD Million) by Type (2016-2021)
Table 57. Global Adult and Pediatric Vaccines Revenue Share by Type (2016-2021)
Table 58. Global Adult and Pediatric Vaccines Revenue Forecast by Type (2021-2026)
Table 59. Global Adult and Pediatric Vaccines Revenue by Application (2016-2021)
Table 60. Global Adult and Pediatric Vaccines Revenue Forecast by Application (2021-2026)
Table 61. North America Adult and Pediatric Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Adult and Pediatric Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Adult and Pediatric Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Adult and Pediatric Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Adult and Pediatric Vaccines Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Adult and Pediatric Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Adult and Pediatric Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Adult and Pediatric Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Adult and Pediatric Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Adult and Pediatric Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Adult and Pediatric Vaccines Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Adult and Pediatric Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Adult and Pediatric Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Adult and Pediatric Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Adult and Pediatric Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Adult and Pediatric Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Adult and Pediatric Vaccines Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Adult and Pediatric Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Adult and Pediatric Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Adult and Pediatric Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Adult and Pediatric Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Adult and Pediatric Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Adult and Pediatric Vaccines Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Adult and Pediatric Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Adult and Pediatric Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Adult and Pediatric Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Adult and Pediatric Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Adult and Pediatric Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Adult and Pediatric Vaccines Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Adult and Pediatric Vaccines Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Adult and Pediatric Vaccines Picture
Figure 2. Global Adult and Pediatric Vaccines Revenue Market Share by Type in 2020
Figure 3. Adult Vaccines
Figure 4. Pediatric Vaccines
Figure 5. Adult and Pediatric Vaccines Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Medical Care Centers Picture
Figure 8. Others Picture
Figure 9. Global Adult and Pediatric Vaccines Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Adult and Pediatric Vaccines Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Adult and Pediatric Vaccines Revenue Market Share by Region (2016-2026)
Figure 12. Global Adult and Pediatric Vaccines Revenue Market Share by Region in 2020
Figure 13. North America Adult and Pediatric Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Adult and Pediatric Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Adult and Pediatric Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Adult and Pediatric Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Adult and Pediatric Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Adult and Pediatric Vaccines Market Drivers
Figure 19. Adult and Pediatric Vaccines Market Restraints
Figure 20. Adult and Pediatric Vaccines Market Trends
Figure 21. GlaxoSmithKline Recent Developments and Future Plans
Figure 22. Sanofi Recent Developments and Future Plans
Figure 23. Merck Recent Developments and Future Plans
Figure 24. Novartis Recent Developments and Future Plans
Figure 25. Pfizer Recent Developments and Future Plans
Figure 26. AstraZeneca Recent Developments and Future Plans
Figure 27. Johnson and Johnson Recent Developments and Future Plans
Figure 28. Takeda Pharmaceutical Recent Developments and Future Plans
Figure 29. Bavarian Nordic Recent Developments and Future Plans
Figure 30. LG Life Sciences Recent Developments and Future Plans
Figure 31. Sinovac Biotech Recent Developments and Future Plans
Figure 32. Global Adult and Pediatric Vaccines Revenue Share by Players in 2020
Figure 33. Adult and Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Adult and Pediatric Vaccines Revenue Market Share in 2020
Figure 35. Global Top 10 Players Adult and Pediatric Vaccines Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Adult and Pediatric Vaccines Revenue Share by Type in 2020
Figure 38. Global Adult and Pediatric Vaccines Market Share Forecast by Type (2021-2026)
Figure 39. Global Adult and Pediatric Vaccines Revenue Share by Application in 2020
Figure 40. Global Adult and Pediatric Vaccines Market Share Forecast by Application (2021-2026)
Figure 41. North America Adult and Pediatric Vaccines Sales Market Share by Type (2016-2026)
Figure 42. North America Adult and Pediatric Vaccines Sales Market Share by Application (2016-2026)
Figure 43. North America Adult and Pediatric Vaccines Revenue Market Share by Country (2016-2026)
Figure 44. United States Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Adult and Pediatric Vaccines Sales Market Share by Type (2016-2026)
Figure 48. Europe Adult and Pediatric Vaccines Sales Market Share by Application (2016-2026)
Figure 49. Europe Adult and Pediatric Vaccines Revenue Market Share by Country (2016-2026)
Figure 50. Germany Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Adult and Pediatric Vaccines Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Adult and Pediatric Vaccines Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Adult and Pediatric Vaccines Revenue Market Share by Region (2016-2026)
Figure 58. China Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Adult and Pediatric Vaccines Sales Market Share by Type (2016-2026)
Figure 65. South America Adult and Pediatric Vaccines Sales Market Share by Application (2016-2026)
Figure 66. South America Adult and Pediatric Vaccines Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Adult and Pediatric Vaccines Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Adult and Pediatric Vaccines Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Adult and Pediatric Vaccines Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Adult and Pediatric Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source

---